Does BELATACEPT Cause Polyomavirus-associated nephropathy? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Polyomavirus-associated nephropathy have been filed in association with BELATACEPT (NULOJIX). This represents 0.8% of all adverse event reports for BELATACEPT.
27
Reports of Polyomavirus-associated nephropathy with BELATACEPT
0.8%
of all BELATACEPT reports
5
Deaths
16
Hospitalizations
How Dangerous Is Polyomavirus-associated nephropathy From BELATACEPT?
Of the 27 reports, 5 (18.5%) resulted in death, 16 (59.3%) required hospitalization, and 6 (22.2%) were considered life-threatening.
Is Polyomavirus-associated nephropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELATACEPT. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does BELATACEPT Cause?
Off label use (304)
Death (206)
Transplant rejection (178)
Cytomegalovirus infection (142)
Drug ineffective (142)
Product storage error (142)
Acute kidney injury (137)
Covid-19 (129)
Hospitalisation (123)
Kidney transplant rejection (97)
What Other Drugs Cause Polyomavirus-associated nephropathy?
TACROLIMUS (1,477)
MYCOPHENOLATE MOFETIL (1,112)
PREDNISONE (666)
METHYLPREDNISOLONE (416)
PREDNISOLONE (402)
BASILIXIMAB (298)
EVEROLIMUS (247)
CYCLOSPORINE (246)
MYCOPHENOLIC ACID (238)
RITUXIMAB (236)
Which BELATACEPT Alternatives Have Lower Polyomavirus-associated nephropathy Risk?
BELATACEPT vs BELIMUMAB
BELATACEPT vs BELINOSTAT
BELATACEPT vs BELUMOSUDIL
BELATACEPT vs BELVIQ
BELATACEPT vs BELZUTIFAN